The efficacy and safety of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor, in patients with advanced head and neck mucosal melanoma harboring CDK4 amplification
Chaoji Shi(National Clinical Research Center for Digestive Diseases), Guoxin Ren(Shanghai Ninth People's Hospital), Ziyue Gu(National Clinical Research Center for Digestive Diseases), Yong Han(Binzhou Medical University), Chuwen Li(State Key Laboratory of Respiratory Disease), Guoyu Zhou(Shanghai Ninth People's Hospital), Houyu Ju(Shanghai Jiao Tong University), Shuyang Sun(Guangxi Medical University), Rong Zhou(Shanghai Ninth People's Hospital), Xinyi Huang(Yanbian University), Jiang Li(Chengdu University of Technology), Zhiyuan Zhang(Tianjin Normal University), Min Wang(Zhongshan People's Hospital), Yunteng Wu(Shanghai Ninth People's Hospital), Yinghan Wang(Sun Yat-sen University), Wanling Chen(Shanghai Jiao Tong University), Shengming Xu(Tsinghua University)
Cited by 7
Related Papers
Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246/SPRED2/MAPK signaling pathway
|Journal of Experimental & Clinical Cancer Research|2019|409
Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005–2014
|Clinical Microbiology and Infection|2016|376
Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma
|Oncotarget|2014|339
High salt primes a specific activation state of macrophages, M(Na)
|Cell Research|2015|243
Nanomaterials for Cancer Precision Medicine
|Advanced Materials|2018|212